Article
Measurement of the plasma levels of antibodies against the polymorphic vaccine candidate apical membrane antigen 1 in a malaria-exposed population.
BMC infectious diseases - 2 Feb 2012
Kusi Kwadwo A, Dodoo Daniel, Bosomprah Samuel, van der Eijk Marjolein, Faber Bart W, Kocken Clemens H M, Remarque Edmond J
Abstract excerpt
BACKGROUND: Establishing antibody correlates of protection against malaria in human field studies and clinical trials requires, amongst others, an accurate estimation of antibody levels. For polymorphic antigens such as apical membrane antigen 1 (AMA1), this may be confounded by the occurrence of a large number of allelic variants in nature. METHODS: To test this hypothesis, plasma antibody levels in an...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
